Incidence of childhood primary immune thrombocytopenic purpura

被引:14
|
作者
Higashigawa, Masamune [1 ]
Maeyama, Takatoshi [1 ]
Yoshino, Ayako [1 ]
Matsuda, Kazuyuki [1 ]
Ito, Mitsue [1 ]
Maji, Tomoaki [1 ]
Ichimi, Ryouji [1 ]
机构
[1] Ise Red Cross Hosp, Dept Pediat, Ise, Mie 5168512, Japan
关键词
child; immune thrombocytopenic purpura; incidence;
D O I
10.1111/ped.12788
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
There is a discrepancy in the reported incidence of childhood immune thrombocytopenic purpura (ITP) between Europe (2.9-5.3 per 100 000 persons) and Japan (1.91). Ise district is a suitable area in which to conduct epidemiological study because there is little fluctuation in the sociodemographic factors. We performed a retrospective population-based study to clarify the incidence of primary childhood ITP. We calculated person-years for children aged <15 years based on the Ise district demographics between 2002 and 2012. The calculated person-years were 298 533. The number of hospitalized patients in Ise district was 25 (M/F, 14/11) during the study period. The calculated incidence was therefore 8.4 per 100 000 person-years. It is possible that the difference in incidence between the present calculation and that of the European studies is due to variation in accuracy and/or registration criteria between the studies.
引用
收藏
页码:1041 / 1043
页数:3
相关论文
共 50 条
  • [21] Immune thrombocytopenic purpura: epidemiology and implications for patients
    Michel, Marc
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 : 3 - 7
  • [22] THE ASSOCIATION OF IMMUNE THROMBOCYTOPENIC PURPURA WITH HEREDITARY SPHEROCYTOSIS
    Sac, Rukiye
    Guveloglu, Mine
    Bostanci, Ilknur
    Tazegul, Aysu
    Dallar, Yildiz
    MARMARA MEDICAL JOURNAL, 2009, 22 (02): : 142 - 145
  • [23] Cytokines and immunoglobulin derangement in egyptian children with primary immune thrombocytopenic purpura
    Fatma, Ebeid S. E.
    Ahmed, Khalifa S.
    Nihal, El-Kinawy S.
    Salwa, Helmy Y.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (01): : 1 - 4
  • [24] Alternative therapy for persistent childhood immune thrombocytopenic purpura unresponsive to intravenous immunoglobulin
    Huang, Tzu-Ping
    Chang, Yu-Han
    Chen, Shih-Hsiang
    Yang, Shu-Ling
    Yen, Hung-Rong
    COMPLEMENTARY THERAPIES IN MEDICINE, 2013, 21 (05) : 525 - 528
  • [25] Anti-β2-glycoprotein I in childhood immune thrombocytopenic purpura
    El-Bostany, Eman A.
    El-Ghoroury, Eman A.
    El-Ghafar, Esmat A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (01) : 26 - 31
  • [26] A case of immune thrombocytopenic purpura presenting with intracranial hemorrhage
    Akbayrami, Sinan
    Aktar, Fesih
    Akgun, Cihangir
    Bektas, Mehmet Selcuk
    Caksen, Huseyin
    Onert, Ahmet Faik
    JOURNAL OF ACUTE DISEASE, 2013, 2 (03) : 250 - 251
  • [27] Chronic immune thrombocytopenic purpura in adults
    Itzykson, Raphael
    Raffoux, Emmanuel
    HEMATOLOGIE, 2009, 15 (02): : 148 - 153
  • [28] DANAZOL THERAPY IN IMMUNE THROMBOCYTOPENIC PURPURA
    MARWAHA, RK
    SINGH, RP
    GAREWAL, G
    MARWAHA, N
    PRAKASH, D
    SARODE, R
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1990, 7 (02) : 193 - 198
  • [29] Immune thrombocytopenic purpura: Pathophysiology and treatment
    Godeau, B.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2009, 16 (02) : 101 - 105
  • [30] Recurrent immune thrombocytopenic purpura in children
    Jayabose, Somasundaram
    Levendoglu-Tugal, Oya
    Ozkaynak, Mehmet F.
    Sandoval, Claudio
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23 (08) : 677 - 682